Carter BZ - Search Results

1

Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through Smo/Gli-1 pathway in acute myeloid leukemia.

Jiang X, Jiang L, Cheng J, Chen F, Ni J, Yin C, Wang Q, Wang Z, Fang D, Yi Z, Yu G, Zhong Q, Carter BZ, Meng F. Jiang X, et al. Among authors: carter bz. J Transl Med. 2021 Mar 21;19(1):117. doi: 10.1186/s12967-021-02789-3. J Transl Med. 2021. PMID: 33743723 Free PMC article.

2

Cytokine-regulated expression of survivin in myeloid leukemia.

Carter BZ, Milella M, Altieri DC, Andreeff M. Carter BZ, et al. Blood. 2001 May 1;97(9):2784-90. doi: 10.1182/blood.v97.9.2784. Blood. 2001. PMID: 11313272 Free article.

3

Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia.

Milella M, Kornblau SM, Estrov Z, Carter BZ, Lapillonne H, Harris D, Konopleva M, Zhao S, Estey E, Andreeff M. Milella M, et al. Among authors: carter bz. J Clin Invest. 2001 Sep;108(6):851-9. doi: 10.1172/JCI12807. J Clin Invest. 2001. PMID: 11560954 Free PMC article.

4

Regulation and targeting of antiapoptotic XIAP in acute myeloid leukemia.

Carter BZ, Milella M, Tsao T, McQueen T, Schober WD, Hu W, Dean NM, Steelman L, McCubrey JA, Andreeff M. Carter BZ, et al. Leukemia. 2003 Nov;17(11):2081-9. doi: 10.1038/sj.leu.2403113. Leukemia. 2003. PMID: 12970762

5

XIAP antisense therapy with AEG 35156 in acute myeloid leukemia.

Katragadda L, Carter BZ, Borthakur G. Katragadda L, et al. Among authors: carter bz. Expert Opin Investig Drugs. 2013 May;22(5):663-70. doi: 10.1517/13543784.2013.789498. Expert Opin Investig Drugs. 2013. PMID: 23586880 Review.

6

Apoptosis repressor with caspase recruitment domain is regulated by MAPK/PI3K and confers drug resistance and survival advantage to AML.

Mak PY, Mak DH, Mu H, Shi Y, Ruvolo P, Ruvolo V, Jacamo R, Burks JK, Wei W, Huang X, Kornblau SM, Andreeff M, Carter BZ. Mak PY, et al. Among authors: carter bz. Apoptosis. 2014 Apr;19(4):698-707. doi: 10.1007/s10495-013-0954-z. Apoptosis. 2014. PMID: 24337870 Free PMC article.

7

The hypomethylating agent decitabine prior to chemotherapy improves the therapy efficacy in refractory/relapsed acute myeloid leukemia patients.

Jiang X, Wang Z, Ding B, Yin C, Zhong Q, Carter BZ, Yu G, Jiang L, Ye J, Dai M, Zhang Y, Liang S, Zhao Q, Liu Q, Meng F. Jiang X, et al. Among authors: carter bz. Oncotarget. 2015 Oct 20;6(32):33612-22. doi: 10.18632/oncotarget.5600. Oncotarget. 2015. PMID: 26384351 Free PMC article.

8

Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells.

Carter BZ, Mak PY, Mu H, Zhou H, Mak DH, Schober W, Leverson JD, Zhang B, Bhatia R, Huang X, Cortes J, Kantarjian H, Konopleva M, Andreeff M. Carter BZ, et al. Sci Transl Med. 2016 Sep 7;8(355):355ra117. doi: 10.1126/scitranslmed.aag1180. Sci Transl Med. 2016. PMID: 27605552 Free PMC article.

9

miR-150 exerts antileukemia activity in vitro and in vivo through regulating genes in multiple pathways.

Fang ZH, Wang SL, Zhao JT, Lin ZJ, Chen LY, Su R, Xie ST, Carter BZ, Xu B. Fang ZH, et al. Among authors: carter bz. Cell Death Dis. 2016 Sep 22;7(9):e2371. doi: 10.1038/cddis.2016.256. Cell Death Dis. 2016. PMID: 27899822 Free PMC article.

10

Glioblastoma and acute myeloid leukemia: malignancies with striking similarities.

Goethe E, Carter BZ, Rao G, Pemmaraju N. Goethe E, et al. Among authors: carter bz. J Neurooncol. 2018 Jan;136(2):223-231. doi: 10.1007/s11060-017-2676-5. Epub 2017 Dec 1. J Neurooncol. 2018. PMID: 29196926 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page